It keeps the food log close to the shot, symptoms, hydration, weight trend, progress layer, medication-level context, Journey Cards, and Capy instead of treating nutrition as a separate macro math problem
[00:16:32] Emily Field: The gym can be so many things beyond a calorie burning tool
Transdermal delivery works well for small, lipophilic (fat-soluble) molecules with specific molecular weights that can penetrate skin effectively
#Immunology #Innovation #BiotechM&A #PharmaStrategy #Type2Inflammation To view or add a comment, sign in Drug Discovery Digest | This Weeks Industry Roundup Obesity, Innovation & the Future of R&D Discovery on Target 2026 is comingregister by June 12 to take advantage of the next savings deadline: Here are four developments shaping the future of drug discovery and development Science & Clinical Updates The Next Wave of Obesity Drug Readouts Is Here With multiple companies racing to compete in the obesity market, recent clinical updates from Pfizer, Lilly, and Viking are helping define the next generation of weight-loss therapies and differentiation strategies
Our review of the clinical trial pipeline reveals 39 new GLP-1 drugs in development from 34 companies, with only seven among the top 20 pharmaceutical companies
Latest study data shows durable response (maintenance data: 75% reduction in Eczema Area and Severity Index (EASI-75) through week 52)